Click for best price
Minimally Invasive Treatment of Lung Cancer Market Size, Share 2023
The minimally invasive treatment method for lung cancer is to cut relatively small wounds around the lung, and then perform local resection through thoracoscopy. The skin injury is relatively small during the operation, and the recovery period after the operation will be very short.
This report contains market size and forecasts of Minimally Invasive Treatment of Lung Cancer in Global, including the following market information:
The global Minimally Invasive Treatment of Lung Cancer market was valued at million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Lung Tumor Ablation Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Minimally Invasive Treatment of Lung Cancer include Medtronic, Olympus, LungCare, Broncus, Intuitive Surgica, Auris Health, Angiodynamics, Boston Scientific and Smith and Nephew, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Minimally Invasive Treatment of Lung Cancer companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Minimally Invasive Treatment of Lung Cancer Market, by Type, 2018-2023, 2023-2030 ($ millions)
Global Minimally Invasive Treatment of Lung Cancer Market Segment Percentages, by Type, 2022 (%)
- Lung Tumor Ablation
- Lung Tumor Embolization
Global Minimally Invasive Treatment of Lung Cancer Market, by Application, 2018-2023, 2023-2030 ($ millions)
Global Minimally Invasive Treatment of Lung Cancer Market Segment Percentages, by Application, 2022 (%)
- Hospitals
- Ambulatory Surgical Centers
Global Minimally Invasive Treatment of Lung Cancer Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions)
Global Minimally Invasive Treatment of Lung Cancer Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Minimally Invasive Treatment of Lung Cancer revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Minimally Invasive Treatment of Lung Cancer revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Medtronic
- Olympus
- LungCare
- Broncus
- Intuitive Surgica
- Auris Health
- Angiodynamics
- Boston Scientific
- Smith and Nephew
- VISON Medical
- Nanjing MICRO-TECH
| Report Attributes |
Report Details |
| Report Title |
Minimally Invasive Treatment of Lung Cancer Market, Global Outlook and Forecast 2023-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
63 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Minimally Invasive Treatment of Lung Cancer Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Minimally Invasive Treatment of Lung Cancer Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Minimally Invasive Treatment of Lung Cancer Overall Market Size
2.1 Global Minimally Invasive Treatment of Lung Cancer Market Size: 2022 VS 2030
2.2 Global Minimally Invasive Treatment of Lung Cancer Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Minimally Invasive Treatment of Lung Cancer Players in Global Market
3.2 Top Global Minimally Invasive Treatment of Lung Cancer Companies Ranked by Revenue
3.3 Global Minimally Invasive Treatment of Lung Cancer Revenue by Companies
3.4 Top 3 and Top 5 Minimally Invasive Treatment of Lung Cancer Companies in Global Market, by Revenue in 2022
3.5 Global Companies Minimally Invasive Treatment of Lung Cancer Product Type
3.6 Tier 1, Tier 2 and Tier 3 Minimally Invasive Treatment of Lung Cancer Players in Global Market
3.6.1 List of Global Tier 1 Minimally Invasive Treatment of Lung Cancer Companies
3.6.2 List of Global Tier 2 and Tier 3 Minimally Invasive Treatment of Lung Cancer Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Minimally Invasive Treatment of Lung Cancer Market Size Markets, 2022 & 2030
4.1.2 Lung Tumor Ablation
4.1.3 Lung Tumor Embolization
4.2 By Type - Global Minimally Invasive Treatment of Lung Cancer Revenue & Forecasts
4.2.1 By Type - Global Minimally Invasive Treatment of Lung Cancer Revenue, 2018-2023
4.2.2 By Type - Global Minimally Invasive Treatment of Lung Cancer Revenue, 2023-2030
4.2.3 By Type - Global Minimally Invasive Treatment of Lung Cancer Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Minimally Invasive Treatment of Lung Cancer Market Size, 2022 & 2030
5.1.2 Hospitals
5.1.3 Ambulatory Surgical Centers
5.2 By Application - Global Minimally Invasive Treatment of Lung Cancer Revenue & Forecasts
5.2.1 By Application - Global Minimally Invasive Treatment of Lung Cancer Revenue, 2018-2023
5.2.2 By Application - Global Minimally Invasive Treatment of Lung Cancer Revenue, 2023-2030
5.2.3 By Application - Global Minimally Invasive Treatment of Lung Cancer Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Minimally Invasive Treatment of Lung Cancer Market Size, 2022 & 2030
6.2 By Region - Global Minimally Invasive Treatment of Lung Cancer Revenue & Forecasts
6.2.1 By Region - Global Minimally Invasive Treatment of Lung Cancer Revenue, 2018-2023
6.2.2 By Region - Global Minimally Invasive Treatment of Lung Cancer Revenue, 2023-2030
6.2.3 By Region - Global Minimally Invasive Treatment of Lung Cancer Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Minimally Invasive Treatment of Lung Cancer Revenue, 2018-2030
6.3.2 US Minimally Invasive Treatment of Lung Cancer Market Size, 2018-2030
6.3.3 Canada Minimally Invasive Treatment of Lung Cancer Market Size, 2018-2030
6.3.4 Mexico Minimally Invasive Treatment of Lung Cancer Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Minimally Invasive Treatment of Lung Cancer Revenue, 2018-2030
6.4.2 Germany Minimally Invasive Treatment of Lung Cancer Market Size, 2018-2030
6.4.3 France Minimally Invasive Treatment of Lung Cancer Market Size, 2018-2030
6.4.4 U.K. Minimally Invasive Treatment of Lung Cancer Market Size, 2018-2030
6.4.5 Italy Minimally Invasive Treatment of Lung Cancer Market Size, 2018-2030
6.4.6 Russia Minimally Invasive Treatment of Lung Cancer Market Size, 2018-2030
6.4.7 Nordic Countries Minimally Invasive Treatment of Lung Cancer Market Size, 2018-2030
6.4.8 Benelux Minimally Invasive Treatment of Lung Cancer Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Minimally Invasive Treatment of Lung Cancer Revenue, 2018-2030
6.5.2 China Minimally Invasive Treatment of Lung Cancer Market Size, 2018-2030
6.5.3 Japan Minimally Invasive Treatment of Lung Cancer Market Size, 2018-2030
6.5.4 South Korea Minimally Invasive Treatment of Lung Cancer Market Size, 2018-2030
6.5.5 Southeast Asia Minimally Invasive Treatment of Lung Cancer Market Size, 2018-2030
6.5.6 India Minimally Invasive Treatment of Lung Cancer Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Minimally Invasive Treatment of Lung Cancer Revenue, 2018-2030
6.6.2 Brazil Minimally Invasive Treatment of Lung Cancer Market Size, 2018-2030
6.6.3 Argentina Minimally Invasive Treatment of Lung Cancer Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Minimally Invasive Treatment of Lung Cancer Revenue, 2018-2030
6.7.2 Turkey Minimally Invasive Treatment of Lung Cancer Market Size, 2018-2030
6.7.3 Israel Minimally Invasive Treatment of Lung Cancer Market Size, 2018-2030
6.7.4 Saudi Arabia Minimally Invasive Treatment of Lung Cancer Market Size, 2018-2030
6.7.5 UAE Minimally Invasive Treatment of Lung Cancer Market Size, 2018-2030
7 Players Profiles
7.1 Medtronic
7.1.1 Medtronic Corporate Summary
7.1.2 Medtronic Business Overview
7.1.3 Medtronic Minimally Invasive Treatment of Lung Cancer Major Product Offerings
7.1.4 Medtronic Minimally Invasive Treatment of Lung Cancer Revenue in Global Market (2018-2023)
7.1.5 Medtronic Key News
7.2 Olympus
7.2.1 Olympus Corporate Summary
7.2.2 Olympus Business Overview
7.2.3 Olympus Minimally Invasive Treatment of Lung Cancer Major Product Offerings
7.2.4 Olympus Minimally Invasive Treatment of Lung Cancer Revenue in Global Market (2018-2023)
7.2.5 Olympus Key News
7.3 LungCare
7.3.1 LungCare Corporate Summary
7.3.2 LungCare Business Overview
7.3.3 LungCare Minimally Invasive Treatment of Lung Cancer Major Product Offerings
7.3.4 LungCare Minimally Invasive Treatment of Lung Cancer Revenue in Global Market (2018-2023)
7.3.5 LungCare Key News
7.4 Broncus
7.4.1 Broncus Corporate Summary
7.4.2 Broncus Business Overview
7.4.3 Broncus Minimally Invasive Treatment of Lung Cancer Major Product Offerings
7.4.4 Broncus Minimally Invasive Treatment of Lung Cancer Revenue in Global Market (2018-2023)
7.4.5 Broncus Key News
7.5 Intuitive Surgica
7.5.1 Intuitive Surgica Corporate Summary
7.5.2 Intuitive Surgica Business Overview
7.5.3 Intuitive Surgica Minimally Invasive Treatment of Lung Cancer Major Product Offerings
7.5.4 Intuitive Surgica Minimally Invasive Treatment of Lung Cancer Revenue in Global Market (2018-2023)
7.5.5 Intuitive Surgica Key News
7.6 Auris Health
7.6.1 Auris Health Corporate Summary
7.6.2 Auris Health Business Overview
7.6.3 Auris Health Minimally Invasive Treatment of Lung Cancer Major Product Offerings
7.6.4 Auris Health Minimally Invasive Treatment of Lung Cancer Revenue in Global Market (2018-2023)
7.6.5 Auris Health Key News
7.7 Angiodynamics
7.7.1 Angiodynamics Corporate Summary
7.7.2 Angiodynamics Business Overview
7.7.3 Angiodynamics Minimally Invasive Treatment of Lung Cancer Major Product Offerings
7.7.4 Angiodynamics Minimally Invasive Treatment of Lung Cancer Revenue in Global Market (2018-2023)
7.7.5 Angiodynamics Key News
7.8 Boston Scientific
7.8.1 Boston Scientific Corporate Summary
7.8.2 Boston Scientific Business Overview
7.8.3 Boston Scientific Minimally Invasive Treatment of Lung Cancer Major Product Offerings
7.8.4 Boston Scientific Minimally Invasive Treatment of Lung Cancer Revenue in Global Market (2018-2023)
7.8.5 Boston Scientific Key News
7.9 Smith and Nephew
7.9.1 Smith and Nephew Corporate Summary
7.9.2 Smith and Nephew Business Overview
7.9.3 Smith and Nephew Minimally Invasive Treatment of Lung Cancer Major Product Offerings
7.9.4 Smith and Nephew Minimally Invasive Treatment of Lung Cancer Revenue in Global Market (2018-2023)
7.9.5 Smith and Nephew Key News
7.10 VISON Medical
7.10.1 VISON Medical Corporate Summary
7.10.2 VISON Medical Business Overview
7.10.3 VISON Medical Minimally Invasive Treatment of Lung Cancer Major Product Offerings
7.10.4 VISON Medical Minimally Invasive Treatment of Lung Cancer Revenue in Global Market (2018-2023)
7.10.5 VISON Medical Key News
7.11 Nanjing MICRO-TECH
7.11.1 Nanjing MICRO-TECH Corporate Summary
7.11.2 Nanjing MICRO-TECH Business Overview
7.11.3 Nanjing MICRO-TECH Minimally Invasive Treatment of Lung Cancer Major Product Offerings
7.11.4 Nanjing MICRO-TECH Minimally Invasive Treatment of Lung Cancer Revenue in Global Market (2018-2023)
7.11.5 Nanjing MICRO-TECH Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Minimally Invasive Treatment of Lung Cancer Market Opportunities & Trends in Global Market
Table 2. Minimally Invasive Treatment of Lung Cancer Market Drivers in Global Market
Table 3. Minimally Invasive Treatment of Lung Cancer Market Restraints in Global Market
Table 4. Key Players of Minimally Invasive Treatment of Lung Cancer in Global Market
Table 5. Top Minimally Invasive Treatment of Lung Cancer Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Minimally Invasive Treatment of Lung Cancer Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Minimally Invasive Treatment of Lung Cancer Revenue Share by Companies, 2018-2023
Table 8. Global Companies Minimally Invasive Treatment of Lung Cancer Product Type
Table 9. List of Global Tier 1 Minimally Invasive Treatment of Lung Cancer Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Minimally Invasive Treatment of Lung Cancer Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Minimally Invasive Treatment of Lung Cancer Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Minimally Invasive Treatment of Lung Cancer Revenue in Global (US$, Mn), 2023-2030
Table 14. By Application ? Global Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Minimally Invasive Treatment of Lung Cancer Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Minimally Invasive Treatment of Lung Cancer Revenue in Global (US$, Mn), 2023-2030
Table 17. By Region ? Global Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Minimally Invasive Treatment of Lung Cancer Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Minimally Invasive Treatment of Lung Cancer Revenue (US$, Mn), 2023-2030
Table 20. By Country - North America Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2023-2030
Table 22. By Country - Europe Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2023-2030
Table 24. By Region - Asia Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2023-2030
Table 26. By Country - South America Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2023-2030
Table 28. By Country - Middle East & Africa Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2023-2030
Table 30. Medtronic Corporate Summary
Table 31. Medtronic Minimally Invasive Treatment of Lung Cancer Product Offerings
Table 32. Medtronic Minimally Invasive Treatment of Lung Cancer Revenue (US$, Mn), (2018-2023)
Table 33. Olympus Corporate Summary
Table 34. Olympus Minimally Invasive Treatment of Lung Cancer Product Offerings
Table 35. Olympus Minimally Invasive Treatment of Lung Cancer Revenue (US$, Mn), (2018-2023)
Table 36. LungCare Corporate Summary
Table 37. LungCare Minimally Invasive Treatment of Lung Cancer Product Offerings
Table 38. LungCare Minimally Invasive Treatment of Lung Cancer Revenue (US$, Mn), (2018-2023)
Table 39. Broncus Corporate Summary
Table 40. Broncus Minimally Invasive Treatment of Lung Cancer Product Offerings
Table 41. Broncus Minimally Invasive Treatment of Lung Cancer Revenue (US$, Mn), (2018-2023)
Table 42. Intuitive Surgica Corporate Summary
Table 43. Intuitive Surgica Minimally Invasive Treatment of Lung Cancer Product Offerings
Table 44. Intuitive Surgica Minimally Invasive Treatment of Lung Cancer Revenue (US$, Mn), (2018-2023)
Table 45. Auris Health Corporate Summary
Table 46. Auris Health Minimally Invasive Treatment of Lung Cancer Product Offerings
Table 47. Auris Health Minimally Invasive Treatment of Lung Cancer Revenue (US$, Mn), (2018-2023)
Table 48. Angiodynamics Corporate Summary
Table 49. Angiodynamics Minimally Invasive Treatment of Lung Cancer Product Offerings
Table 50. Angiodynamics Minimally Invasive Treatment of Lung Cancer Revenue (US$, Mn), (2018-2023)
Table 51. Boston Scientific Corporate Summary
Table 52. Boston Scientific Minimally Invasive Treatment of Lung Cancer Product Offerings
Table 53. Boston Scientific Minimally Invasive Treatment of Lung Cancer Revenue (US$, Mn), (2018-2023)
Table 54. Smith and Nephew Corporate Summary
Table 55. Smith and Nephew Minimally Invasive Treatment of Lung Cancer Product Offerings
Table 56. Smith and Nephew Minimally Invasive Treatment of Lung Cancer Revenue (US$, Mn), (2018-2023)
Table 57. VISON Medical Corporate Summary
Table 58. VISON Medical Minimally Invasive Treatment of Lung Cancer Product Offerings
Table 59. VISON Medical Minimally Invasive Treatment of Lung Cancer Revenue (US$, Mn), (2018-2023)
Table 60. Nanjing MICRO-TECH Corporate Summary
Table 61. Nanjing MICRO-TECH Minimally Invasive Treatment of Lung Cancer Product Offerings
Table 62. Nanjing MICRO-TECH Minimally Invasive Treatment of Lung Cancer Revenue (US$, Mn), (2018-2023)
List of Figures
Figure 1. Minimally Invasive Treatment of Lung Cancer Segment by Type in 2022
Figure 2. Minimally Invasive Treatment of Lung Cancer Segment by Application in 2022
Figure 3. Global Minimally Invasive Treatment of Lung Cancer Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Minimally Invasive Treatment of Lung Cancer Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Minimally Invasive Treatment of Lung Cancer Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Minimally Invasive Treatment of Lung Cancer Revenue in 2022
Figure 8. By Type - Global Minimally Invasive Treatment of Lung Cancer Revenue Market Share, 2018-2030
Figure 9. By Application - Global Minimally Invasive Treatment of Lung Cancer Revenue Market Share, 2018-2030
Figure 10. By Region - Global Minimally Invasive Treatment of Lung Cancer Revenue Market Share, 2018-2030
Figure 11. By Country - North America Minimally Invasive Treatment of Lung Cancer Revenue Market Share, 2018-2030
Figure 12. US Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2018-2030
Figure 13. Canada Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2018-2030
Figure 14. Mexico Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2018-2030
Figure 15. By Country - Europe Minimally Invasive Treatment of Lung Cancer Revenue Market Share, 2018-2030
Figure 16. Germany Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2018-2030
Figure 17. France Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2018-2030
Figure 18. U.K. Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2018-2030
Figure 19. Italy Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2018-2030
Figure 20. Russia Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2018-2030
Figure 21. Nordic Countries Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2018-2030
Figure 22. Benelux Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2018-2030
Figure 23. By Region - Asia Minimally Invasive Treatment of Lung Cancer Revenue Market Share, 2018-2030
Figure 24. China Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2018-2030
Figure 25. Japan Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2018-2030
Figure 26. South Korea Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2018-2030
Figure 27. Southeast Asia Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2018-2030
Figure 28. India Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2018-2030
Figure 29. By Country - South America Minimally Invasive Treatment of Lung Cancer Revenue Market Share, 2018-2030
Figure 30. Brazil Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2018-2030
Figure 31. Argentina Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2018-2030
Figure 32. By Country - Middle East & Africa Minimally Invasive Treatment of Lung Cancer Revenue Market Share, 2018-2030
Figure 33. Turkey Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2018-2030
Figure 34. Israel Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2018-2030
Figure 35. Saudi Arabia Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2018-2030
Figure 36. UAE Minimally Invasive Treatment of Lung Cancer Revenue, (US$, Mn), 2018-2030
Figure 37. Medtronic Minimally Invasive Treatment of Lung Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 38. Olympus Minimally Invasive Treatment of Lung Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 39. LungCare Minimally Invasive Treatment of Lung Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 40. Broncus Minimally Invasive Treatment of Lung Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 41. Intuitive Surgica Minimally Invasive Treatment of Lung Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Auris Health Minimally Invasive Treatment of Lung Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Angiodynamics Minimally Invasive Treatment of Lung Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Boston Scientific Minimally Invasive Treatment of Lung Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Smith and Nephew Minimally Invasive Treatment of Lung Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. VISON Medical Minimally Invasive Treatment of Lung Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Nanjing MICRO-TECH Minimally Invasive Treatment of Lung Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
